Abstract
Literary data gives evidence that placenta is a rich source of stem cells that phenotypically correspond to human mesenchymal stem cells. The possibility of osteogenic and hepatogenic differentiation of placental mesenchymal stem cells was reported as well as their transformation into cardiomyocytes, adipocytes was shown. It was established that mesenchymal stem cells of placenta have the highest potential of osteogenic differentiation compared to the stem cells from other sources. The advantages of placental stem cells towards clinical application are ethical feasibility and non-invasive collection, high proliferative potential and immunomodulatory properties.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
